Remifentanil Use in Infants and Children

Marcia L. Buck, Pharm.D., FCCP, FPPAG


Pediatr Pharm. 2013;19(5) 

In This Article


Remifentanil, a μ-opioid agonist with a rapid onset and short duration of action, has become a valuable component of general anesthesia in infants, children, and adults since it was approved by the Food and Drug Administration in 1996.[1,2] Although it is not yet approved for procedural or postoperative analgesia in infants or children, a growing number of recent studies suggest that remifentanil has the potential to be of benefit in these settings as well.